# Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

> **NCT07729137** · PHASE2 · RECRUITING · sponsor: **Emmecell** · enrollment: 121 (estimated)

## Conditions studied

- Corneal Edema
- Fuchs
- Fuchs Dystrophy
- Fuchs' Endothelial Dystrophy
- Endothelial Corneal Dystrophy
- Corneal Endothelial Decompensation
- Corneal Endothelial Cell Loss
- Corneal Endothelial Disorder
- Corneal Endothelial Dystrophy 1
- Endothelial Cell Loss, Corneal
- Pseudophakic Bullous Keratopathy
- Pseudophakic Bullous Keratopathy (PBK)

## Interventions

- **BIOLOGICAL:** 150K cells
- **BIOLOGICAL:** 500K cells
- **PROCEDURE:** Placebo

## Key facts

- **NCT ID:** NCT07729137
- **Lead sponsor:** Emmecell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-08
- **Final completion:** 2028-02
- **Target enrollment:** 121 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07729137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07729137, "Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07729137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*